Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Enteric Diseases Laboratory Branch

National Antimicrobial Resistance Surveillance Team (NARST)

The National Antimicrobial Resistance Surveillance Team conducts antimicrobial resistance surveillance and applied research among foodborne enteric bacteria (pathogens and commensal organisms). Susceptibility testing and other analyses are performed on bacterial isolates from foodborne disease outbreaks, focus studies, and human isolate submissions to the National Antimicrobial Resistance Monitoring System (NARMS). NARMS is a collaboration between the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration Center for Veterinary Medicine (FDA-CVM), and the United States Department of Agricultural Research Service (USDA-ARS). NARMS human isolate monitoring is conducted in partnership with the Enteric Diseases Epidemiology Surveillance Branch; FDA-CVM and USDA-ARS conduct studies on bacteria isolated from retail meats and food animals, respectively.

Publications

NARMS 2010 Annual report [PDF - 75 pages]

NARMS 2009 Annual report [PDF - 75 pages]

NARMS 2008 Annual report [PDF - 73 pages]

NARMS 2007 Annual report [PDF - 66 pages]

National Antimicrobial Resistance Monitoring System - Enteric Bacteria (NARMS) 2006 Annual Report [PDF - 69 pages] (Published in partnership with Enteric Diseases Epidemiology Branch, EDEB-NARMS)

National Antimicrobial Resistance Monitoring System - Enteric Bacteria (NARMS) Executive report 2005 (Published in partnership with EDEB-NARMS, FDA-CVM and USDA)

Folster JP, Rickert R, Barzilay EJ, Whichard JM Identification of the aminoglycoside resistance determinants, armA and rmtC, among human non-Typhi Salmonella isolated in the United States. Antimicrobial Agents Chemother. 2009 [in press]

Sjölund-Karlsson M, Folster JP, Joyce K, Medalla F, Rickert R and. Whichard JM
Emergence of Plasmid-mediated Quinolone Resistance among Non-Typhi Salmonella enterica Isolated from Humans in the United States Antimicrob Agents Chemother. 2009 May;53(5):2142-4.

Whichard, J. M., K. Gay, J. E. Stevenson, K. J. Joyce, K. L. Cooper, M. Omondi, F. Medalla, G. A. Jacoby, and T. J. Barrett.. Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Emerg Infect Dis 2007, 13:1681-8.

 
 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO